BioCentury
ARTICLE | Company News

Genzyme reducing headcount

September 10, 2010 11:10 PM UTC

Genzyme Corp. (NASDAQ:GENZ) said on Friday it will reduce headcount but does not plan to release further details until next week. The company has 12,800 employees. In May, Genzyme announced plans to reduce costs and pursue strategic alternatives for three of its businesses. Genzyme was up $0.16 to $70.79 on Friday. ...